DDW: Duodenal Switch Outperforms Gastric Bypass

For the "super-obese," duodenal switch surgery appears to be superior to gastric bypass for resolving obesity-related comorbidities, a researcher said here.

Three years after surgery, patients with a body mass index of 50 kg/m² or higher who underwent the duodenal switch procedure were less likely to need medications for diabetes, hypertension, and dyslipidemia, than those who underwent Roux-en-Y gastric bypass, Vivek Prachand, M.D., of the University of Chicago, reported at Digestive Disease Week. Click here for full article.